ES2181593A1 - Metodo para la obtencion de implantes bioactivos utiles como sistemas de liberacion controlada de antibioticos. - Google Patents

Metodo para la obtencion de implantes bioactivos utiles como sistemas de liberacion controlada de antibioticos.

Info

Publication number
ES2181593A1
ES2181593A1 ES200101386A ES200101386A ES2181593A1 ES 2181593 A1 ES2181593 A1 ES 2181593A1 ES 200101386 A ES200101386 A ES 200101386A ES 200101386 A ES200101386 A ES 200101386A ES 2181593 A1 ES2181593 A1 ES 2181593A1
Authority
ES
Spain
Prior art keywords
implants
bone
antibiotics
systems
controlled release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200101386A
Other languages
English (en)
Other versions
ES2181593B2 (es
Inventor
Regi Maria Vallet
Prudencio Carmen Victori Ragel
Navarrete Daniel Arcos
Sainz Manuel Clavel
Olmo Luis Meseguer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Complutense de Madrid
Original Assignee
Universidad Complutense de Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Complutense de Madrid filed Critical Universidad Complutense de Madrid
Priority to ES200101386A priority Critical patent/ES2181593B2/es
Priority to PCT/ES2002/000301 priority patent/WO2002102430A1/es
Publication of ES2181593A1 publication Critical patent/ES2181593A1/es
Application granted granted Critical
Publication of ES2181593B2 publication Critical patent/ES2181593B2/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/10—Ceramics or glasses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Ceramic Engineering (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Método para la obtención de implantes bioactivos útiles como sistemas de liberación controlada de antibióticos. La invención consiste en un método en el que se lleva a cabo el control del tamaño de grano de un vidrio bioactivo, la mezcla de dicho vidrio con un antibiótico, el conformado de la mezcla aplicando presión de tipo uniaxial y posterior prensado isostático. Se obtienen piezas compactas para ser implantadas en el tejido óseo capaces de proporcionar dosis efectivas de antibiótico a nivel local. Los implantes presentan capacidad para promover la regeneración ósea. De aplicación en cirugía ortopédica para relleno de defectos óseos de cualquier etiología y en la prevención y tratamiento de infecciones óseas de origen bacteriano.
ES200101386A 2001-06-14 2001-06-14 Metodo para la obtencion de implantes bioactivos utiles como sistemas de liberacion controlada de antibioticos. Expired - Lifetime ES2181593B2 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES200101386A ES2181593B2 (es) 2001-06-14 2001-06-14 Metodo para la obtencion de implantes bioactivos utiles como sistemas de liberacion controlada de antibioticos.
PCT/ES2002/000301 WO2002102430A1 (es) 2001-06-14 2002-06-14 Metodo para la obtencion de implantes bioactivos utiles como sistemas de liberacion controlada de antibioticos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101386A ES2181593B2 (es) 2001-06-14 2001-06-14 Metodo para la obtencion de implantes bioactivos utiles como sistemas de liberacion controlada de antibioticos.

Publications (2)

Publication Number Publication Date
ES2181593A1 true ES2181593A1 (es) 2003-02-16
ES2181593B2 ES2181593B2 (es) 2004-04-16

Family

ID=8498070

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200101386A Expired - Lifetime ES2181593B2 (es) 2001-06-14 2001-06-14 Metodo para la obtencion de implantes bioactivos utiles como sistemas de liberacion controlada de antibioticos.

Country Status (2)

Country Link
ES (1) ES2181593B2 (es)
WO (1) WO2002102430A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US9364565B2 (en) 2000-03-15 2016-06-14 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods of using same
ES2393980T3 (es) * 2003-09-30 2013-01-03 Adc Advanced Dental Care Gmbh & Co Kg Método para producir un material de sustitución ósea
CN105497990B (zh) * 2016-01-14 2019-11-29 聊城大学 一种三维多孔钛基镁掺杂涂层及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011853A1 (en) * 1996-09-19 1998-03-26 Usbiomaterials Corporation Composition and method for acceleration of wound and burn healing
WO1998040113A1 (en) * 1997-03-13 1998-09-17 University Of Florida Tissue Bank, Inc. Bone paste
US5874109A (en) * 1994-07-27 1999-02-23 The Trustees Of The University Of Pennsylvania Incorporation of biological molecules into bioactive glasses

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874109A (en) * 1994-07-27 1999-02-23 The Trustees Of The University Of Pennsylvania Incorporation of biological molecules into bioactive glasses
WO1998011853A1 (en) * 1996-09-19 1998-03-26 Usbiomaterials Corporation Composition and method for acceleration of wound and burn healing
WO1998040113A1 (en) * 1997-03-13 1998-09-17 University Of Florida Tissue Bank, Inc. Bone paste

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ARCOS et al. "Bioactivity in glass/PMMA composites used as drug delivery system", Biomaterials, abril 2001, volumen 2, nö 7, páginas 701-708, ISSN 0142-9612. *
RAGEL et al. "In vitro bioactivity and gentamicine release from glass-polymer-antibiotics composites", J. Biomed. Mat. Res., septiembre 2000, volumen 51, nö 3, páginas 424-429, ISSN 0021-9304. *

Also Published As

Publication number Publication date
ES2181593B2 (es) 2004-04-16
WO2002102430A1 (es) 2002-12-27

Similar Documents

Publication Publication Date Title
WO2002041837A3 (en) Treatment of mucositis
WO2005114323A3 (en) Manufacturing process of three dimensional printing
HK1068640A1 (en) Time release calcium sulfate matrix for bone augmentation
WO2007044229A3 (en) Surface treatments for calcium phosphate-based implants
AU2002251982A1 (en) Orthopedic implant and method for orthopedic treatment
AU2002365380A1 (en) Implant, method of making the same and use thereof for the treating of bones defects
AU2003211140A1 (en) Composition and method for inducing bone growth and healing
WO2002067998A3 (en) Devices and methods for the treatment of cancer
WO2001015715A3 (en) Composition for maintenance of bone or dental health or treatment of bone or dental disorders
IL173878A0 (en) Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
EP2266584A3 (en) Composition with strontium and vitamin D for the prophylaxis and/or treatment of cartilage and/or bone conditions
WO2007096748A3 (en) Biomaterial and an injectable implant thereof, method of preparation and use
WO2008046405A3 (de) Behandlung von osteoporose
Su et al. A new type of biphasic calcium phosphate cement as a gentamicin carrier for osteomyelitis
ES2181593A1 (es) Metodo para la obtencion de implantes bioactivos utiles como sistemas de liberacion controlada de antibioticos.
AU2003270196A1 (en) Method for preventing or reducing secondary fractures after hip fracture
WO2005013900A3 (en) Method and composition for treating peridontal disease
CA2531488A1 (en) Use of antiseptic active principles in polymethyl methacrylate bone cements
Nandi et al. In vitro and in vivo release of cefuroxime axetil from bioactive glass as an implantable delivery system in experimental osteomyelitis
WO2003093419A3 (en) Preventing secondary lymphedema with vegf-d dna
WO2007019453A3 (en) Treatment of wounds using il-17b
RU2335258C2 (ru) Способ изготовления имплантата для пластики дефектов костной ткани
Brand 50 Years Ago in CORR: The Use of Plaster of Paris to Fill Defects in Bone Leonard F. Peltier, MD CORR 1961; 21: 1–31
Babiak et al. Antimicrobial biomaterials in the prevention and local treatment of infection in orthopedics
AU2002360218A1 (en) A METHOD OF TREATING BACTERIAL INFECTIONS USING GEMIFLOXACIN OR A SALT THEREOF AND A Beta -LACTAM ANTIBIOTIC

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030216

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2181593B2

Country of ref document: ES